bioAffinity Technologies, Inc. (BIAF)
(Delayed Data from NSDQ)
$2.72 USD
-0.18 (-6.21%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $2.69 -0.03 (-1.10%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BIAF 2.72 -0.18(-6.21%)
Will BIAF be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for BIAF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BIAF
BIAF Stock Down Following Q2 Earnings Despite CyPath Lung Growth
The Zacks Analyst Blog Highlights Meta Platforms, ServiceNow, Booking, Vaso and bioAffinity Technologies
BIAF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Top Research Reports for Meta Platforms, ServiceNow & Booking
BIAF Stock Rises Post Q1 Earnings Despite Revenue Decline
The Zacks Analyst Blog Highlights Alphabet, Berkshire Hathaway, Visa and bioAffinity Technologies
Other News for BIAF
Is BIAF coiling for a breakout? Narrow Range Bar shows up after tumbling 6.21%
BIAF forms Narrow Range Bar on October 9
BioAffinity Technologies announces closing of $1.8M registered direct offering
BioAffinity Technologies announces closing of $1.8M registered direct offering
Directional Movement Crossover Bullish appears for BIAF after 24.49% move